Search ))
Minneapolis Law Firm

PRACTICES

Securities

DOWNLOAD PDF ))

Oppenheimer advises both emerging and public clients—ranging in size from small reporting companies to large accelerated filers listed on the NYSE and NASDAQ.


Recent Experience
  • We have represented clients in a wide variety of capital-raising transactions, including:

 

  • Initial public offerings – American Medical Systems ($68 MM), ev3 ($243 MM), Merrill ($253 MM), Select Comfort ($68 MM)
  • Secondary public offerings – ev3 ($166 MM), Marten Transport ($61 MM) and Select Comfort ($80 MM)
  • Shelf registration statements and takedowns - American Medical Systems ($325 MM), Toro ($125 MM), and BioSante Pharmaceuticals ($50 MM)
  • Registered direct offerings – BioSante Pharmaceuticals ($85 MM in seven offerings over four years)
  • Private investments in public equity (PIPE) transactions – BioSante Pharmaceuticals ($18 MM) and Southwest Casino ($12 MM)
  • Equity lines of credit and committed equity financing facilities – BioSante Pharmaceuticals ($25 MM)
  • More than 100 private placements of debt and equity, including venture capital investments (see our MedTech Practice)
  • We regularly advise our public company clients in:

 

  • Sales and purchases of public and private companies (see our M&A Practice)
  • SEC public reporting requirements
  • Regulation FD compliance
  • Sarbanes-Oxley Act of 2002 compliance
  • Corporate governance
  • Stock exchange regulation
  • Equity and other compensation matters

Securities Team
Client List

Oppenheimer serves as primary securities counsel for the following public companies:

 

AetriumBioSante PharmaceuticalsEcolab  
Marten TransportMOCONNorthern Technologies
Select ComfortTornierToro
Attorney Contact
Bruce Machmeier 
612.607.7267
Securities Client Alerts
All Practice Areas